Anderson v. State

663 P.2d 570, 135 Ariz. 578, 1982 Ariz. App. LEXIS 682
CourtCourt of Appeals of Arizona
DecidedAugust 24, 1982
Docket1 CA-CIV 5946
StatusPublished
Cited by8 cases

This text of 663 P.2d 570 (Anderson v. State) is published on Counsel Stack Legal Research, covering Court of Appeals of Arizona primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Anderson v. State, 663 P.2d 570, 135 Ariz. 578, 1982 Ariz. App. LEXIS 682 (Ark. Ct. App. 1982).

Opinion

OPINION

CONTRERAS, Judge.

At issue is the right of an adult who has not been adjudged incompetent but who is involuntarily committed to the Arizona State Hospital (ASH) to refuse, in non-emergency situations, to take psychotropic (anti-psychotic) drugs prescribed for his treatment. We conclude that such drugs can only be administered in strict accordance with the Arizona Mental Health Services Act (MHSA), and that, absent the statutory preconditions, the trial court erred in ordering administration of such drugs to appellant. We therefore reverse and remand.

FACTUAL BACKGROUND

Appellant is a 31-year-old man who has spent most of the last decade in various penal and psychiatric institutions. The period of confinement which gave rise to this legal action began in October 1977 when appellant was committed to ASH under the provisions of Rule 11, Arizona Rules of Criminal Procedure. In November 1977, his commitment was changed to civil commitment. On June 2, 1978, R. Robertson Kenner, M.D., Superintendent of ASH, filed a petition for court-ordered treatment, pursuant to A.R.S. § 36-533, alleging that appellant was a danger to both himself and others, and in need of treatment. The affidavit of John W. Marchildon, M.D., stated that appellant

has a long history of antisocial behavior which is inadequately handled because of his frequent involvement in the behavioral health system as he is subject to psychotic episodes which may be either endogenous or drug induced. He currently presents a management problem, even on the Maximum Security ward. He resists therapeutic efforts, including medication, and is without insight into the dangerousness, inappropriateness, and illegality of his acts.

The affidavit of Harrison M. Baker, M.D., stated that appellant

represents an admixture of schizophrenia and antisocial personality.

On June 8, 1978, the trial court, after an appearance by appellant, ordered him to be hospitalized at ASH for a period not to exceed 180 days. Similar petitions were filed approximately every six months thereafter, and each time hospitalization was ordered for an additional period not to exceed 180 days. Appellant was released from treatment on July 1, 1980, but a new petition was filed, and treatment ordered, later in the same month.

Appellant has steadfastly maintained his unwillingness to accept psychotropic medication, and has repeatedly complained of side effects. On several occasions, he has *580 sought relief in the courts. Appellant filed a request for judicial review in February 1979; it was denied in March 1979. At a hearing on December 3, 1979, appellant, through appointed counsel, made an oral motion for an order allowing him to refuse treatment. Each party submitted a memorandum of points arid authorities, and the motion was denied by a minute entry dated January 11, 1980, which was reduced to a signed order dated March 20, 1981. The order provides, in pertinent part:

Now therefore, the court finds that for the patient Mathew Anderson to receive proper hospital treatment it is necessary that conventional psychotropic medications for treatment be administered against the will and wishes of the patient.
It is therefore ordered denying patient’s motion and it is further ordered that the Arizona State Hospital shall administer any conventional psychotropic medication to the patient with or without patient’s consent that the medical director of said hospital deems appropriate in the treatment of this patient.

This appeal follows.

MEDICAL BACKGROUND

During his hospitalization, appellant has received several different psychotropic (anti-psychotic) drugs, including:

Prolixin-D (fluphenazine hydrochloride)

Permitil (fluphenazine hydrochloride)

Trilaphon (perphenazine)

Stelazine (trifluoperazine hydrochloride)

Vistaril (hydroxyzine hydrochloride)

Thorazine (chlorpromazine hydrochloride)

Haldol (haloperidol)

On the basis of a record much more extensive than that before this court, a federal district court summarized the effects of such anti-psychotic drugs as follows:

Anti-psychotic drugs are chemical agents used to manage and treat serious mental illness. They are also referred to as neuroleptic drugs and psychotropic drugs.... In general, the drugs influence chemical transmissions to the brain, affecting both activatory and inhibitory functions. Because the drugs’ purpose is to reduce the level of psychotic thinking, it is virtually undisputed that they are mind-altering.
Foremost among the possible side effects of anti-psychotic drugs is tardive dyskinesia. Tardive dyskinesia is a neurological side effect which may appear after prolonged use of anti-psychotic drug treatment. The disease is the outcome of a complex patient-drug interaction which is not currently well understood. The overt symptoms of tardive dyskinesia include certain involuntary motor movements, particularly of the face, lips, and tongue. Tardive dyskinesia can also cause the involuntary movement of fingers, hands, legs and the pelvic area. In its most progressive state, the disease can interfere with swallowing and can affect all motor activity. While in mild cases the disease can simply be a source of embarrassment, it can be physically and psychologically disabling. Until very recently, tardive dyskinesia was considered irreversible. Some studies now suggest that in certain cases it can be effectively treated.
Recent studies also suggest that tar-dive dyskinesia is more widespread in mental patients than previously considered. Two studies now place the prevalence of tardive dyskinesia among chronically hospitalized schizophrenics at 50% and 56%. With respect to out-patients, one survey has reported a prevalence rate of 41%....
There are also a variety of neurological side effects of anti-psychotic drugs, known as extrapyramidal effects. These include akathisia (motor restlessness — the inability to sit still), akanesia (physical immobility and lack of spontaneity), dystonia (spasmodic muscle reaction frequently characterized by a twisting of the neck) and pseudo-parkinsonian syndrome (mask-like face, rigidity of the hand). These conditions are not considered to be irreversible.

(footnotes omitted). Rogers v. Okin, 478 F.Supp. 1342, 1360 (D.Mass.1979), affirmed in part, reversed in part, 634 F.2d 650 (1st *581 Cir.1980), remanded sub nom Mills v. Rogers, 457 U.S. 291, 102 S.Ct. 2442, 73 L.Ed.2d 16 (1982).

The objectionable side effects of psychotropic medications can be to some extent ameliorated with other medications.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Arizona Cannabis Nurses Ass'n v. Arizona Department of Health Services
392 P.3d 506 (Court of Appeals of Arizona, 2017)
In Re Mh2010-002348
268 P.3d 392 (Court of Appeals of Arizona, 2011)
Arnold v. Arizona Department of Health Services
775 P.2d 521 (Arizona Supreme Court, 1989)
Rivers v. Katz
495 N.E.2d 337 (New York Court of Appeals, 1986)
United Farm Workers v. Arizona Agricultural Employment Relations Board
716 P.2d 439 (Court of Appeals of Arizona, 1986)
Large v. Superior Court
714 P.2d 399 (Arizona Supreme Court, 1986)

Cite This Page — Counsel Stack

Bluebook (online)
663 P.2d 570, 135 Ariz. 578, 1982 Ariz. App. LEXIS 682, Counsel Stack Legal Research, https://law.counselstack.com/opinion/anderson-v-state-arizctapp-1982.